Dementia Discovery Fund is a specialist venture capital fund that invests in novel science to create meaningful new medicines.
The Dementia Discovery Fund is the world’s largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease.The DDF has raised a total of £250 million to develop novel disease-modifying therapeutics for all forms of dementia.They have a mandate to validate novel hypotheses and expand the breadth of targets and mechanisms in development for dementia over the 15 year life of the fund.This enables the DDF to invest in truly novel, early-stage projects starting from target identification, and explore novel biological insights for translation into disease-modifying drugs.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
Amphista Therapeutics
|
Series B | — | Biopharma | Yes |
May 4, 2021
Cumulus Neuroscience
|
Series Unknown | £6M | Health Care | Yes |
Apr 15, 2021
Alchemab Therapeutics
|
Series A | £60M | Biotechnology | — |
Dec 8, 2020
BrainWaveBank
|
Convertable Note | £6M | Clinical Trials | Yes |
Apr 30, 2018
Evelo Biosciences
|
Series Unknown | $47.50M | Biotechnology | Yes |